Harvard Bioscience (HBIO) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.52% |
| Dec 31, 2025 | -4.36% |
| Sep 30, 2025 | -2.29% |
| Jun 30, 2025 | -3.60% |
| Mar 31, 2025 | -1.26% |
| Dec 31, 2024 | -4.06% |
| Sep 30, 2024 | -3.15% |
| Jun 30, 2024 | -3.69% |
| Mar 31, 2024 | -1.77% |
| Dec 31, 2023 | -2.72% |
| Sep 30, 2023 | -1.42% |
| Jun 30, 2023 | 1.66% |
| Mar 31, 2023 | 6.69% |
| Dec 31, 2022 | 7.52% |
| Sep 30, 2022 | 5.08% |
| Jun 30, 2022 | 12.89% |
| Mar 31, 2022 | 11.05% |
| Dec 31, 2021 | 10.07% |
| Sep 30, 2021 | 6.89% |
| Jun 30, 2021 | 6.97% |
| Mar 31, 2021 | 3.58% |
| Dec 31, 2020 | 6.50% |
| Sep 30, 2020 | 2.85% |
| Jun 30, 2020 | 1.93% |
| Mar 31, 2020 | 2.49% |
| Dec 31, 2019 | 4.45% |
| Sep 30, 2019 | 5.53% |
| Jun 30, 2019 | 5.38% |
| Mar 31, 2019 | 6.55% |
| Dec 31, 2018 | 9.24% |
| Sep 30, 2018 | 6.96% |
| Jun 30, 2018 | 4.90% |
| Mar 31, 2018 | 1.59% |
| Dec 31, 2017 | -3.83% |
| Sep 30, 2017 | -4.52% |
| Jun 30, 2017 | -7.77% |
| Mar 31, 2017 | -6.47% |
| Dec 31, 2016 | -1.76% |
| Sep 30, 2016 | -0.32% |
| Jun 30, 2016 | -1.80% |
| Mar 31, 2016 | 0.91% |
| Dec 31, 2015 | -2.15% |
| Sep 30, 2015 | -1.38% |
| Jun 30, 2015 | 0.89% |